Venture-Backed Startups
82,427 companies with verified investor relationships.
Attunement provides AI-powered tools for interpreting complex medical records and supporting clinical documentation workflows in healthcare settings. The platform integrates with EHR systems and maintains patient context while generating report-ready outputs with built-in clinician oversight.
1 investor
0 investors
0 investors
0 investors
Atuin is a developer tool that syncs, searches, and backs up shell history across machines with end-to-end encryption, and includes an integrated AI assistant accessible directly from the terminal prompt.
3 investors
Atum Labs is building payment infrastructure and solutions for the financial sector.
1 investor
Atum Works develops scalable 3D lithography technology capable of printing metal structures with submicron resolution for advanced manufacturing applications.
4 investors
Atum Labs is a technology company developing software products and offering custom software development services. Details on its specific products have not yet been published.
1 investor
atVenu provides technology tools and services for live events, including point-of-sale and operational software designed to handle high-volume scenarios at festivals, concerts, and tours.
2 investors
A leading provider of engineering, consulting, and construction services.
1 investor
atwork helps organizations reduce absenteeism and stabilize teams through workforce management and wellbeing solutions, serving healthcare delivery organizations.
1 investor
0 investors
0 investors
Atyati provides a technology platform for rural and last-mile banking, enabling banks and financial institutions to deliver microfinance and banking services to underserved populations through business correspondent agents. The platform includes core tools like loan origination, portfolio management, and agent dashboards that integrate with bank systems.
1 investor
1 investor
0 investors
aTyr is a clinical-stage biotechnology company developing therapies derived from tRNA synthetase biology to treat fibrosis and inflammation, with its lead candidate efzofitimod in clinical trials for interstitial lung disease. The company leverages a proprietary discovery platform targeting immune-mediated disorders in pulmonary and systemic conditions.
3 investors
Identity verification flows loved by users, hated by bad actors.
2 investors
0 investors
0 investors
0 investors
0 investors
Auction Mobility is a sales enablement platform that helps customers increase their sales through its product offerings.
1 investor
0 investors